Amlodipine Besylate and Benazepril Hydrochloride

Product NDC
63629-7643
11-digit product format
636297643
Labeler code
63629
Product ID
63629-7643_aab4b82c-24bd-484a-8f4d-0e190f2a0a9d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Amlodipine Besylate and Benazepril Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA077183
Marketing category
ANDA
Marketing start
2010-04-19
Marketing end
0000-00-00
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Active strength
3 mg/1; mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-7643-16362976430130 CAPSULE in 1 BOTTLE (63629-7643-1) 30 capsule2018-06-080000-00-00NoNoCurrent
63629-7643-26362976430290 CAPSULE in 1 BOTTLE (63629-7643-2) 90 capsule2018-06-080000-00-00NoNoCurrent